Indivior Provides Statement on RB Settlement
Updated : 13:19
This regulatory news is for Private Investors only
RNS Number : 2715F
Indivior PLC
11 July 2019
11 July 2019
US Government Settlement with Reckitt Benckiser Group
Indivior PLC (the Group) notes today's announcement of Reckitt Benckiser Group's (RB) settlement with various US Government entities in relation to investigations into past sales and marketing of SUBOXONE® Film.
As previously stated, Indivior PLC's case with the US Department of Justice (DOJ) is separate from that of RB, and Indivior has no additional or new information related to this matter.
Investors are referred to the Indivior's previous statements on the DOJ matter, including those contained within its Q1 2019 results press release (2 May 2019) and its response to the DOJ's action against the Group (9 April 2019) available at Indivior.com.
-ends-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.